ELVN
Enliven Therapeutics Inc.
44.80$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | – | – | +36.4% | +155.6% | +87.0% | +38.1% | +6.7% | -17.0% | |
| – | – | +62.0% | -85.5% | +1,380.0% | +65.9% | +304.7% | +56.2% | +68.6% | |
| – | – | – | – | -80.4% | – | – | – | – | |
| – | – | -45.5% | -13.4% | +511.8% | -87.7% | +219.9% | -424.1% | – | |
| – | – | – | +229.3% | -58.6% | +220.4% | -75.7% | -70.5% | +259.1% | |
| – | – | – | -98.1% | -58.6% | +220.4% | +24,150.3% | -75.7% | +382.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | -41.0% | +571.7% | +199.5% | -100.8% | +77.1% | – | -43.2% | +64.4% | |
| – | -203.3% | – | – | -116.7% | – | – | -2.6% | -205.4% | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.